Feb. 23 at 5:38 PM
Bidding
$IPDN early. A run from .50 to 1.00 is almost a given at this point, but it could well become the top mega runner of first quarter.
Another one that deserves at least a lotto position IMO is
$SLRN. The smallest hint of positive trial data could send this skyward and beyond. Gene-editing technology is the sexiest thing in bio.
$MERC crowded market but I like the sub-sector.
Anything left for
$LMGK to offer here after this S-1? 24 million warrants… It's served me well in that past, watching, no position. Somebody help me out.